Oday Abushalbaq is a Scientist I specializing in Nucleic Acid Research at Novo Nordisk since January 2024, where contributions include advancing drug target proposals and validating oligonucleotide tissue targeting technologies. Prior experience includes roles as Scientist I in Pharmacology at Alltrna, where Oday focused on preclinical disease models for tRNA drug candidates, and Group Lead/PhD Scholar at Al-Quds University, overseeing research on neuropsychiatric patient profiling. With a strong educational background inclusive of a Ph.D. in Biological and Biomedical Sciences from Rutgers University, an MSc in Cancer Research from The University of Manchester, and multiple BSc degrees in Biotechnology, Oday has also served in leadership and teaching positions, highlighting a commitment to research in molecular and cognitive markers and their applications in understanding various diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices